Shares of Nutriband Inc. (NASDAQ:NTRBW – Get Free Report) traded up 50% during mid-day trading on Friday . The company traded as high as $0.90 and last traded at $1.35. 103 shares were traded during trading, a decline of 95% from the average session volume of 1,965 shares. The stock had previously closed at $0.90.
Nutriband Stock Performance
The stock has a fifty day simple moving average of $1.22 and a 200-day simple moving average of $1.38.
Hedge Funds Weigh In On Nutriband
An institutional investor recently bought a new position in Nutriband stock. Clear Street Group Inc. bought a new position in shares of Nutriband Inc. (NASDAQ:NTRBW – Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 61,590 shares of the company’s stock, valued at approximately $105,000.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.
Featured Articles
- Five stocks we like better than Nutriband
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
